[go: up one dir, main page]

BR0316687A - Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos - Google Patents

Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos

Info

Publication number
BR0316687A
BR0316687A BR0316687-2A BR0316687A BR0316687A BR 0316687 A BR0316687 A BR 0316687A BR 0316687 A BR0316687 A BR 0316687A BR 0316687 A BR0316687 A BR 0316687A
Authority
BR
Brazil
Prior art keywords
membrane vesicles
adjuvant
living organisms
obtaining
outer membrane
Prior art date
Application number
BR0316687-2A
Other languages
English (en)
Inventor
Gustavo Rafael Bracho Granado
Concepcion Campa Huergo
Nestor Mora Gonzalez
Ramon Faustino Barbera Morales
Judit Monica Del Campo Alonso
Tamara Rodriguez Ramirez
Caridad Zayas Vignier
Danay Gil Martinez
Carlos Taboada Suarez
Oliver German Perez Martin
Miriam De San Juan Bo Gonzalez
Victoriano Gustavo Si Gonzalez
Original Assignee
Inst Finlay Ct De Investigacio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Finlay Ct De Investigacio filed Critical Inst Finlay Ct De Investigacio
Publication of BR0316687A publication Critical patent/BR0316687A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/002Protozoa antigens
    • A61K39/008Leishmania antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0275Salmonella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588Adjuvants of undefined constitution
    • A61K2039/55594Adjuvants of undefined constitution from bacteria
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO E ADJUVANTE VACINAL E MéTODO PARA A OBTENçãO DE ESTRUTURAS COCLEARES A PARTIR DE VESìCULAS DE MEMBRANA EXTERNA DE ORGANISMOS VIVOS". A presente invenção refere-se ao campo da imunologia, particularmente ao ramo referente aos adjuvantes e às vacinas. O objetivo técnico perseguido é o de obter estruturas cocleares a partir de vesículas de membrana externa (ampolas) de microorganismos, com o fim de empregá-las como adjuvantes ou como vacinas propriamente ditas. A invenção também se refere ao método de obtenção das estruturas cocleares.
BR0316687-2A 2002-11-27 2003-11-27 Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos BR0316687A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CU20020292A CU23313A1 (es) 2002-11-27 2002-11-27 Mã0/00todo de obtenciã"n de estructuras cocleares. composiciones vacunales y adyuvantes basados en estructuras cocleares y sus intermediarios
PCT/CU2003/000016 WO2004047805A1 (es) 2002-11-27 2003-11-27 Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios.

Publications (1)

Publication Number Publication Date
BR0316687A true BR0316687A (pt) 2005-10-18

Family

ID=40122451

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0316687-2A BR0316687A (pt) 2002-11-27 2003-11-27 Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos

Country Status (14)

Country Link
US (1) US20060134134A1 (pt)
EP (2) EP2347764A3 (pt)
CN (1) CN1744883B (pt)
AR (1) AR042237A1 (pt)
AT (1) ATE530166T1 (pt)
AU (1) AU2003281911A1 (pt)
BR (1) BR0316687A (pt)
CA (1) CA2518906A1 (pt)
CU (1) CU23313A1 (pt)
DK (1) DK1602360T3 (pt)
ES (1) ES2376227T3 (pt)
HK (1) HK1088827A1 (pt)
WO (1) WO2004047805A1 (pt)
ZA (1) ZA200504729B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642046B2 (en) * 2007-10-09 2014-02-04 Tufts University Cholera vaccines
CU20080215A7 (es) 2008-11-19 2012-06-21 Inst Finlay Vacunas unitemporales
WO2011027956A2 (ko) * 2009-09-04 2011-03-10 주식회사이언메딕스 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델
CU20100083A7 (es) 2010-05-05 2012-06-21 Inst Finlay Tolerogenos adyuvados como vacuna de malaria
CU20110202A7 (es) 2011-11-02 2013-12-27 Inst Finlay Ct De Investigación Producción De Sueros Y Vacunas Composición inmunogénica de polisacáridos planos adyuvados y las formulaciones resultantes
EP2689775A1 (en) * 2012-07-25 2014-01-29 Instituto Finlay, Centro de Investigacion-Produccion de vacunas y sueros Cochleate with only one mamp
WO2021031270A1 (zh) * 2019-08-22 2021-02-25 四川大学 细菌膜囊泡及其分离制备系统和方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US597572A (en) * 1898-01-18 Indicator for oil-wells
CH588887A5 (pt) 1974-07-19 1977-06-15 Battelle Memorial Institute
GB1578776A (en) 1976-06-10 1980-11-12 Univ Illinois Hemoglobin liposome and method of making the same
GB2026340B (en) 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
DE2848965A1 (de) 1978-11-11 1980-05-22 Behringwerke Ag Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
US4271147A (en) 1980-01-10 1981-06-02 Behringwerke Aktiengesellschaft Process for the isolation of membrane proteins from Neisseria meningitidis and vaccines containing same
US4663161A (en) 1985-04-22 1987-05-05 Mannino Raphael J Liposome methods and compositions
RU2023448C1 (ru) 1987-07-30 1994-11-30 Сентро Насьональ Де Биопрепарадос Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
WO1993014744A1 (en) * 1992-02-04 1993-08-05 Chiron Corporation Non-toxic lipid vaccine formulations
US5994318A (en) * 1993-10-04 1999-11-30 Albany Medical College Cochleate delivery vehicles
US5643574A (en) 1993-10-04 1997-07-01 Albany Medical College Protein- or peptide-cochleate vaccines and methods of immunizing using the same
US5851536A (en) 1995-11-22 1998-12-22 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
US5834015A (en) * 1996-09-11 1998-11-10 Albany Medical College Protein-lipid vesicles and autogenous vaccine comprising the same
US6180114B1 (en) 1996-11-21 2001-01-30 University Of Washington Therapeutic delivery using compounds self-assembled into high axial ratio microstructures
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
NO20002828D0 (no) * 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
GB0103170D0 (en) * 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition

Also Published As

Publication number Publication date
DK1602360T3 (da) 2012-02-13
ATE530166T1 (de) 2011-11-15
EP2347764A3 (en) 2011-10-26
ZA200504729B (en) 2006-09-27
EP2347764A2 (en) 2011-07-27
AR042237A1 (es) 2005-06-15
AU2003281911A1 (en) 2004-06-18
CA2518906A1 (en) 2004-06-10
CN1744883A (zh) 2006-03-08
CN1744883B (zh) 2011-06-08
ES2376227T3 (es) 2012-03-12
EP1602360B1 (en) 2011-10-26
EP1602360A1 (en) 2005-12-07
US20060134134A1 (en) 2006-06-22
WO2004047805A1 (es) 2004-06-10
HK1088827A1 (en) 2006-11-17
CU23313A1 (es) 2008-09-25

Similar Documents

Publication Publication Date Title
Plotkin et al. A short history Section 1 vaccination
AR061333A1 (es) Composiciones de vacuna de la neisseria
BR112012022688A2 (pt) proteína de fusão, vesícula da membrana externa isolada, polinucleotídeo, composição farmacêutica, vacina, método para tratamento ou prevenção de infecção ou doença por neisseria, uso e método para fabricar uma proteína de fusão
BR112012022800A2 (pt) composição imunogênica ou vacina, cepa bacteriana gram-negativa geneticamente engenheirada, métodos para o tratamento ou prevenção de infecção ou doença, para produzir uma composição imunogênica ou uma vacina, e para preparar uma imunoglobulina, preparação da imunoglobulina, e, preparação farmacêutica
BR0015961A (pt) Antìgeno de neisseria de 85kda
EA200900076A1 (ru) Применение определенных алкоксилатов спиртов в качестве адъюванта в области агротехники
WO2002009746A8 (en) Vaccines comprising outer membrane vesciles from gram negative bacteria
BR0316687A (pt) Composição e adjuvante vacinal e método para a obtenção de estruturas cocleares a partir de vesìculas de membrana externa de organismos vivos
PH12019500108A1 (en) Ultraportable system for intra-operative isolation and regulation of surgical site environments
CL2008003202A1 (es) Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
PT1112747E (pt) Vacina de salmonella que nao induz anticorpos contra flagelina ou flagelos
MX2010003220A (es) Proteinas inmunogenicas de membrana exterior derivada de genoma de leptospira y composiciones y metodos basados en las mismas.
RU2014140731A (ru) Варианты гемагглютинина и нейраминидазы гриппа
CL2023001142A1 (es) Composiciones y métodos para la vacunación contra neisseria gonorrhoeae
ES2524468T3 (es) Protección heteróloga contra pasteurella multocida proporcionada por células de P. multocida fur y sus extractos proteicos de membrana externa
Spooner et al. A bacteriologic study of the influenza epidemic at Camp Devens, Mass.
NZ580603A (en) Intradermal influenza vaccine
BR112023003571A2 (pt) Vesículas de membrana externa
Martínez et al. Infective endocarditis of an interventricular patch caused by Acinetobacter haemolyticus
CU23377A1 (es) Metodo para la incorporacion de antigenos en vesiculas de membrana externa de bacterias y formulaciones resultantes
MX2023000097A (es) Adyuvantes de vacunas y metodos de sintetizacion y uso de estos.
RU2002122063A (ru) Штам бактерий leptospira interrogans "митронов" серогруппы canicola для приготовления вакцины
NAM et al. Localized cutaneous infection due to Scedosporium apiospermum
PARK et al. A case of cutaneous infection with Mycobacterium fortuitum
AR046937A1 (es) Proteina nmb0928 y su uso en formulaciones farmaceuticas

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.